Vicus Capital Grows Holdings in CVS Health Corp (CVS)
Vicus Capital boosted its position in shares of CVS Health Corp (NYSE:CVS) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,184 shares of the pharmacy operator’s stock after purchasing an additional 1,365 shares during the period. Vicus Capital’s holdings in CVS Health were worth $1,322,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of CVS. Bell Rock Capital LLC lifted its stake in CVS Health by 764.0% in the 4th quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 382 shares during the last quarter. Daiwa SB Investments Ltd. acquired a new stake in CVS Health in the 4th quarter valued at about $30,000. Acima Private Wealth LLC acquired a new stake in CVS Health in the 4th quarter valued at about $33,000. Cornerstone Advisors Inc. lifted its stake in CVS Health by 71.6% in the 3rd quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock valued at $40,000 after purchasing an additional 212 shares during the last quarter. Finally, Certified Advisory Corp lifted its stake in CVS Health by 46.3% in the 4th quarter. Certified Advisory Corp now owns 638 shares of the pharmacy operator’s stock valued at $42,000 after purchasing an additional 202 shares during the last quarter. Institutional investors own 84.55% of the company’s stock.
Several equities research analysts recently issued reports on CVS shares. Cantor Fitzgerald started coverage on shares of CVS Health in a research note on Monday, November 26th. They issued an “overweight” rating and a $96.00 target price for the company. Wells Fargo & Co raised their price objective on shares of CVS Health from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 27th. Loop Capital set a $80.00 price objective on shares of CVS Health and gave the stock a “hold” rating in a research report on Wednesday, November 28th. Evercore ISI assumed coverage on shares of CVS Health in a research report on Wednesday, November 28th. They set an “outperform” rating and a $89.00 price objective for the company. Finally, Goldman Sachs Group restated a “neutral” rating and set a $87.00 price objective on shares of CVS Health in a research report on Thursday, November 29th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $84.18.
Shares of CVS traded up $0.92 during mid-day trading on Monday, hitting $56.52. 128,261 shares of the company’s stock were exchanged, compared to its average volume of 13,593,090. CVS Health Corp has a 52 week low of $51.93 and a 52 week high of $82.15. The stock has a market capitalization of $70.89 billion, a PE ratio of 7.98, a P/E/G ratio of 1.06 and a beta of 0.95. The company has a current ratio of 1.03, a quick ratio of 0.65 and a debt-to-equity ratio of 1.22.
CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.07 by $0.07. CVS Health had a negative net margin of 0.31% and a positive return on equity of 17.49%. The company had revenue of $54.42 billion for the quarter, compared to analysts’ expectations of $53.78 billion. During the same period last year, the firm earned $1.92 earnings per share. The business’s revenue for the quarter was up 12.5% on a year-over-year basis. Equities research analysts predict that CVS Health Corp will post 6.8 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Tuesday, April 23rd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 22nd. This represents a $2.00 annualized dividend and a dividend yield of 3.54%. CVS Health’s dividend payout ratio is presently 28.25%.
COPYRIGHT VIOLATION WARNING: “Vicus Capital Grows Holdings in CVS Health Corp (CVS)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/vicus-capital-grows-holdings-in-cvs-health-corp-cvs/2899978.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Featured Story: Capital Gains
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.